Claritas Pharmaceuticals

0 followers

‌

Claritas Pharmaceuticals is developing R-107, a nitric oxide-releasing molecule designed to treat vaccine-resistant COVID-19 infection.

Industries

Pharmaceutical

Headquarters

San Francisco, United States

Employees

11-50

Links

Org chart

Robert Farrell

President & CEO

Robert Farrell

Collapse

Nedira Frenkel

Director, Business Development

Yousif Sahly

Director, Quality Control

Gali Guzikevich

Director, Quality Assurance

Amos Rosenthal

Head, Chemistry

Iris Maimon

Director, Drug Development

Teams

Leadership Team

6 members

Similar companies

Bristol-Myers Squibb

175 followers

Lundbeck

31 followers

Catalent

17 followers

PPD

15 followers

Precision Medicine Group

2 followers

Amgen

198 followers

Anthropic

50 followers

THEMAGIC5

60 followers

MarketCast

5 followers

Artisanal Talent Group

6 followers

StorONE

6 followers

Explore companies